TABLE 2.
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | p Value | HR (95% CI) | p Value | |
GLYAT expression | ||||
Low (n = 166) vs. high (n = 69) | 1.943 (1.086–3.476) | 0.025 | 2.184 (1.205–3.959) | 0.010 |
Age | ||||
<60 (n = 125) vs. ≥60 (n = 110) | 1.201 (0.762–1.891) | 0.43 | ||
Gender | ||||
Male (n = 161) vs. Female (n = 74) | 0.778 (0.487–1.244) | 0.294 | ||
Histologic grade | ||||
G1–G2 (n = 132) vs. G3–G4 (n = 103) | 1.071 (0.678–1.690) | 0.769 | ||
TNM stage | ||||
I (n = 113) vs. II–IV (n = 122) | 1.276 (1.128–1.443) | <0.001 | 1.103 (0.937–1.299) | 0.239 |
T stage | ||||
T1–T2 (n = 167) vs. T3–T4 (n = 68) | 3.103 (1.967–4.896) | <0.001 | 2.561 (1.379–4.756) | 0.003 |
N stage | ||||
N0 (n = 231) vs. N1 (n = 4) | 2.064 (0.504–8.448) | 0.313 | ||
M stage | ||||
M0 (n = 231) vs. M1 (n = 4) | 3.925 (1.230–12.522) | 0.021 | 1.505 (0.456–4.967) | 0.502 |
Note: Statistically significant p values are given in bold, P < 0.05.
Abbreviations: CI, confidence interval; GLYAT, Glycine N‐acyltransferase; HR, hazard ratio; TNM, tumour‐node‐metastasis.